002393SZSE

Notice of Convening the 2025 Annual Shareholders' Meeting

✨ AI Summary

Tianjin Life Science & Technology Pharmaceutical Co., Ltd. announces its 2025 Annual Shareholders' Meeting. The meeting will be held on April 15, 2026, with online and in-person voting options. Key agenda items include the Board of Directors' work report, financial reports, profit distribution, annual report, director compensation, related party transactions, and amendments to the Articles of Association.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Securities Code: 002393 Securities Abbreviation: Life Science Pharmaceutical Announcement Number: 2026-024

Tianjin Life Science & Technology Pharmaceutical Co., Ltd. Notice of Convening the 2025 Annual Shareholders' Meeting

The Company and all members of the Board of Directors guarantee that the information disclosed is true, accurate, and complete, and that there are no false records, misleading statements, or major omissions.

The matters related to the Eighth Board of Directors' Fourth Meeting of Tianjin Life Science & Technology Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company" or "this Company"), after being deliberated and approved by the Board of Directors in accordance with the Company's Articles of Association, shall be submitted to the Shareholders' Meeting for deliberation. The relevant matters of the 2025 Annual Shareholders' Meeting are as follows:

I. Basic Information on Convening the Meeting

  1. Session of Shareholders' Meeting: 2025 Annual Shareholders' Meeting
  2. Convenor: The Board of Directors of the Company. This Shareholders' Meeting is convened by the resolution of the Eighth Board of Directors' Fourth Meeting of the Company.
  3. Legality and Compliance of Convening and Holding the Meeting: The convening and holding of this Shareholders' Meeting comply with relevant laws, administrative regulations, departmental rules, normative documents, and the Company's Articles of Association.
  4. Time of Meeting

On-site Meeting Time: 2:45 PM on April 15, 2026 (Wednesday) Online Voting Time: April 15, 2026. The specific time for online voting through the Shenzhen Stock Exchange trading system is 9:15-9:25 AM, 9:30-11:30 AM, and 1:00-3:00 PM on April 15, 2026. The specific time for online voting through the Shenzhen Stock Exchange internet voting system is any time between 9:15 AM and 3:00 PM on April 15, 2026. 5. Equity Registration Date: April 8, 2026 (Wednesday) 6. Meeting Venue: Conference Room of Tianjin Life Science & Technology Pharmaceutical Co., Ltd. No. 16, Saida North Road, Xiqing Economic and Technological Development Area, Tianjin 7. Method of Convening the Meeting: This Shareholders' Meeting will adopt a combination of on-site voting and online voting. The Company will provide an online voting platform for all shareholders through the Shenzhen Stock Exchange trading system and the internet voting system (http://wltp.cninfo.com.cn). Shareholders can exercise their voting rights through the above systems during the online voting period. 8. Attendees: (1) Shareholders who hold shares of the Company or their authorized representatives on the equity registration date. As of the close of trading on April 8, 2026 (Wednesday), all shareholders of the Company registered with the Shenzhen Branch of China Securities Depository and Clearing Corporation Limited are entitled to attend and vote at this meeting in the manner notified. Shareholders who are unable to attend in person for any reason may entrust an authorized representative to attend and vote on their behalf (Power of Attorney format is attached). The authorized representative need not be a shareholder of the Company. (2) Directors and senior management of the Company. (3) Lawyers engaged by the Company for witnessing and other relevant personnel. 9. Method of Attendance: Company shareholders can only choose one method of voting: on-site voting or online voting. If the same voting right is voted on repeatedly, the result of the first vote shall prevail.

II. Matters to be Reviewed at the Meeting

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.